Best FMCG Stocks In India 2024

Date:

Share post:

Hindustan Unilever Ltd

Market Cap  ₹ 606,101 Cr.

Debt  ₹ 1,043 Cr.

ROE  18.4 %

Sales growth  13.2 %

EPS  ₹ 39.0

Industry PE  62.3

Stock P/E  66.0

ROCE  24.4 %

Promoter holding  61.9 %

Pledged percentage  0.00 %

PEG Ratio  4.22

Net profit  ₹ 9,183 Cr.

Return on Equity:

10 Years: 45%

5 Years: 36%

3 Years: 28%

Last Year: 18%

Compounded Profit Growth:

10 Years: 13%

5 Years: 16%

3 Years: 13%

TTM: 11%

Compounded Sales Growth

10 Years: 8%

5 Years: 10%

3 Years: 10%

TTM: 13%

PROS:

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.4%
  • Company has been maintaining a healthy dividend payout of 96.4%

CONS:

  • Stock is trading at 12.4 times its book value
  • The company has delivered a poor sales growth of 9.60% over the past five years.
  • Promoter holding has decreased over last 3 years: -5.28%

Procter & Gamble Hygiene and Health Care Ltd

Market Cap  ₹ 45,860 Cr.

Debt  ₹ 5.10 Cr.

ROE  79.3 %

Sales growth  9.14 %

EPS  ₹ 177

Industry PE  62.3

Stock P/E  79.6

ROCE  110 %

Promoter holding  70.6 %

Net profit  ₹ 576 Cr.

PEG Ratio  14.3

Pledged percentage  0.00 %

Return on Equity:

10 Years: 44%

5 Years: 58%

3 Years: 62%

Last Year: 79%

Compounded Profit Growth:

10 Years: 12%

5 Years: 6%

3 Years: 11%

TTM: -12%

Compounded Sales Growth:

10 Years: 12%

5 Years: 11%

3 Years: 10%

TTM: 9%

PROS:

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 61.7%
  • Company has been maintaining a healthy dividend payout of 109%

CONS:

  • Stock is trading at 62.0 times its book value
  • The company has delivered a poor sales growth of 11.0% over the past five years.

 

Colgate-Palmolive (India) Ltd

Market Cap  ₹ 44,494 Cr.

Debt  ₹ 83.0 Cr.

ROE  74.4 %

Sales growth  3.30 %

EPS  ₹ 38.8

Industry PE  62.3

Stock P/E  42.0

ROCE  92.0 %

Promoter holding  51.0 %

Net profit  ₹ 1,055 Cr.

PEG Ratio  3.15

Pledged percentage  0.00 %

Return on Equity:

10 Years: 65%

5 Years: 60%

3 Years: 67%

Last Year: 74%

Compounded Profit Growth:

10 Years: 9%

5 Years: 13%

3 Years: 13%

TTM: -1%

Compounded Sales Growth:

10 Years: 7%

5 Years: 5%

3 Years: 5%

TTM: 3%

PROS:

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 67.4%
  • Company has been maintaining a healthy dividend payout of 98.0%

CONS:

  1. Stock is trading at 25.8 times its book value
  2. The company has delivered a poor sales growth of 5.07% over the past five years.

 

Related articles

Transchem Share Price Rally: Revenue Zero Hone Ke Baad Bhi Stock Kyu Bhaag Raha Hai?

Transchem Limited haal hi me stock market investors ke beech kaafi charcha ka vishay bani hui hai. Iski...

Mercury Laboratories Analysis: Revenue Growth Zero, Pharma Stock Me Kya Hai Risk?

Mercury Laboratories Limited ek established pharmaceutical company hai jo gynecology aur pediatrics segment ki medicines manufacture karti hai....

CCME Global Analysis: Company Ya Jaal? Investors Ke Liye Badi Warning

CCME Global haal hi me investors ke beech kaafi charcha ka vishay bana hua hai. Share price me...

Albert David Profit Ka Khel? Core Business Kamzor, Other Income Se Positive Bottom Line!

Albert David Ltd ke latest financial results ek mixed picture present karte hain. Pehli nazar me company ka...
WhatsApp chat